The Polytical and Business Daily - March 12, 2008

NEW DELHI: Marck Biosciences is planning to enter the Latin American market and has got the nod from the Brazilian healthcare watchdog, ANVISA, for launching company's product in the country. The company, which is targeting a turnover of Rs 100 crore in the next fiscal, has received ANVISA nod for exporting sterile injectables to Brazil and would roll out its products in Brazil.